This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Sympathetic renal denervation versus increment of ...
Clinical trial

Sympathetic renal denervation versus increment of pharmacological treatment in resistant arterial hypertension

Read time: 1 mins
Last updated:12th Jun 2012
To determine the effect of a percutaneous catheter-based renal sympathetic denervation (RSD) procedure to disrupt renal afferent and efferent nerves using radiofrequency ablation, on 24h ambulatory systolic blood pressure (SBP), in subjects with resistant hypertension (RH), as compared to the addition of spironolactone, an aldosterone receptor blocker, to the baseline pharmacological treatment, from baseline (Visit 0) to Final Examination (Week 24).
Category Value
Study start date 2012-06-12

View full details